{"id":12195,"name":"Biolumina Ventures","slug":"biolumina-ventures","website":"https://www.biolumina.com/","hqGeo":"Austin, TX","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Healthcare","Other","AI / ML","Developer Tools"],"excludedSectors":["Consumer"],"checkSizeMin":500000,"checkSizeMax":3000000,"thesisSummary":"Biolumina Ventures focuses on early-stage biotech startups that are leveraging cutting-edge AI and data analytics to transform drug discovery processes.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Genomify","companyUrl":null,"stage":null,"sector":"Biotech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Surge Therapeutics","companyUrl":null,"stage":"Series B","sector":"Biotechnology / Oncology","investmentYear":null,"description":"Developing intraoperative immunotherapies using biodegradable hydrogels to prevent cancer recurrence.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Enveda Biosciences","companyUrl":null,"stage":"Series B1","sector":"Biotechnology / AI Drug Discovery","investmentYear":null,"description":"Utilizing metabolomics and machine learning to discover novel small-molecule therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Candid Therapeutics","companyUrl":null,"stage":"Series A / Launch","sector":"Biotechnology / Immunology","investmentYear":null,"description":"Developing multi-specific T-cell engagers to deplete B-cells for autoimmune disease treatment.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Capstan Therapeutics","companyUrl":null,"stage":"Series B","sector":"Biotechnology / Cell & Gene Therapy","investmentYear":null,"description":"Developing in vivo CAR-T therapies using a targeted lipid nanoparticle platform.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ReCode Therapeutics","companyUrl":null,"stage":"Series B Extension","sector":"Biotechnology / Genetic Medicine","investmentYear":null,"description":"Developing tissue-specific genetic medicines using a Selective Organ Targeting lipid nanoparticle platform.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":10,"partners":[{"id":39195,"name":"Chelsea Tholen","title":"Senior Vice President, Account Supervisor","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/chelsea-tholen-574a7118","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":39196,"name":"Cait Marconi","title":"Vice President of Strategy","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/cait-marconi-364886b5","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":39197,"name":"Lauren Bradley","title":"Vice President of Project Management","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/lauren-lb-bradley","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":39198,"name":"Terry Mcshane","title":"Associate Creative Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/terry-mcshane-4906b533","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":39199,"name":"Austin Wei","title":"Executive Creative Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/austin-wei-aab1085","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":39200,"name":"Stevenson Hawkey","title":"Senior Vice President, Account Supervisor","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/stevensonhawkey","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":39201,"name":"Dr. Lisa Chen","title":"GP","seniority":null,"focusTags":["Biotech","AI","Drug Discovery"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":39202,"name":"Kirsten Kantak","title":"President and Chief Executive Officer","seniority":null,"focusTags":["healthcare","diagnostics","therapy adoption"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":"Passionate about using her curiosity to build knowledge—for herself and for everyone around her. She is driven by her awareness that the work we do helps ensure that HCPs, patients, and caregivers have the latest information about available treatments, giving them the opportunity to make the best choices.","recentPosts":[]},{"id":39203,"name":"Diane Iler-Smith","title":"Chief Creative Officer","seniority":null,"focusTags":["science","creativity","therapeutic innovation"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":"Knows that curiosity is the glue that binds her two passions: science and creativity. For Diane, curiosity fuels a creative approach that addresses an important purpose—to share the latest scientific advances with the HCPs, patients, and caregivers who are making critical decisions about treatment.","recentPosts":[]},{"id":39204,"name":"Brenda Aske","title":"Chief Strategy Officer","seniority":null,"focusTags":["strategy","emerging technologies","innovation"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":"Believes curiosity is a competitive advantage. She brings together people, ideas, and emerging technologies to challenge assumptions, connect dots others miss, and uncover new possibilities.","recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":6492,"name":"Breed Reply","slug":"breed-reply","logoUrl":null,"website":"https://www.reply.com/","stageFocus":[],"sectorTags":["Healthcare","Security"],"hqGeo":null},{"id":7722,"name":"Sheesha Finance","slug":"sheesha-finance","logoUrl":null,"website":"https://sheeshafinance.gitbook.io/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Fintech"],"hqGeo":null},{"id":2027,"name":"Impact Mental Health VC","slug":"impact-mental-health-vc","logoUrl":null,"website":"https://www.imhpa.org/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","Healthcare"],"hqGeo":"Boston, MA"},{"id":11229,"name":"Meshare Ventures","slug":"meshare-ventures","logoUrl":null,"website":"https://v1.meshare.com/","stageFocus":["Pre-Seed"],"sectorTags":["Other","AI / ML","Fintech"],"hqGeo":"Nairobi, Kenya"},{"id":6827,"name":"Force Over Mass","slug":"force-over-mass","logoUrl":null,"website":"https://www.fomcap.com/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Other","Fintech","SaaS","Healthcare","EdTech"],"hqGeo":null},{"id":5644,"name":"Project Canary Ventures","slug":"project-canary-ventures","logoUrl":null,"website":"https://www.projectcanary.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","AI / ML"],"hqGeo":"Denver, CO"}],"featuredIn":[{"slug":"pre-seed","displayName":"Pre-Seed Investors","pageType":"stage"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"ai","displayName":"AI & ML Investors","pageType":"industry"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-08-12T11:05:53.057Z"}